Filed with the SEC on · accession 0001213900-26-119681
TXMD filed a 8-K (current report) with the SEC on Nov 13, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +2.7% by the first close after the filing.
TherapeuticsMD, Inc. furnished a Form 8-K disclosing its financial results for the quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.
Close before
$1.82
Nov 12, 2026
First close after
+2.75%
$1.87
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for TXMD, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TXMD?
Click hereTXMD filed a 8-K (SEC filing). TherapeuticsMD, Inc. furnished a Form 8-K disclosing its financial results for the quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
TXMD closed at $1.82 before the filing and $1.87 on Nov 13, 2026 (+2.75%).
Get alerts when TXMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days